TISSUE KALLIKREIN-1 FOR TREATING CHRONIC KIDNEY DISEASE
Provided are methods of using human tissue kallikrein-1 (KLK1) to treat chronic kidney disease (CKD) in patients having salt-sensitive hypertension and low KLK1 levels, including methods of identifying and treating optimal sub-populations of CKD patients based on selected genotypes and/or phenotypes...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
28.12.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!